Dylan Orsburn Injured in Crash on Highway 33 Near Kerto Road

Posted on March 25, 2020March 25, 2020 by Staff Writer

Motorcycle, Pickup Truck Collide in Maricopa Accident

Maricopa, CA (March 21, 2020) – A man was injured in a motorcycle crash in Maricopa. The accident occurred on the evening of March 21 on Highway 33.

Taft resident Dylan Orsburn, 24, was riding a motorcycle on southbound Highway 33, near Kerto Road, when he went across the double yellow lines and into oncoming traffic. The motorcycle hit a Dodge Ram pickup driven by William Blize, 74, of Maricopa.

Orsburn lost control and crashed the motorcycle. He was airlifted to a local hospital with serious injuries. Blize remained at the accident scene. He was not hurt in the crash.

The legal team at Nadrich & Cohen hopes that the accident victim makes a speedy and full recovery. We know how difficult it can be to recover physically, emotionally and financially from an auto accident. Let us deal with the insurance companies so that you can focus on treating your injuries and making a full recovery. The law firm of Nadrich & Cohen has handled thousands of accident and personal injury claims since our firm was founded in 1990.

#Maricopa

#93252

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

What can we do for you?

Answer your legal question.

Provide a Free Case Evaluation.

Schedule an appointment.

Why Choose Us?

Available 24/7

Trusted Since 1990

Local to You

Recovered $350,000,000

5 Star Reviews

Free Case Evaluation

VIP Service

No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.